GETTING MY BLOCK PAIN RECEPTORS WITH PROLEVIATE TO WORK

Getting recognized the palmitoylation motif of APLNR, we built a short substrate sequence to competitively inhibit the palmitoylation of endogenous APLNR. This competitive peptide, which targets the APLNR palmitoylation site in combination with morphine, can inhibit the event of NCP, together with pain incidence, microglial activation, and inflamma